Description: Waters Corporation operates as an analytical instrument manufacturer in the United States and internationally. The company's Waters division designs, manufactures, sells, and services high performance liquid chromatography, ultra performance liquid chromatography, and mass spectrometry technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. This segment's products are used to detect, identify, monitor, and measure the chemical, physical, and biological composition of materials, as well as to purify a range of compounds. Its products are also used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its TA division offers thermal analysis, rheometry, and calorimetry instruments, which are used in predicting the suitability of fine chemicals, pharmaceuticals, water, polymers, and viscous liquids for uses in various industrial, consumer goods and healthcare products, as well as for life science research. The company also develops and supplies software-based products that interface with its instruments. Its products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Home Page: www.waters.com
WAT Technical Analysis
34 Maple Street
Milford,
MA
01757
United States
Phone:
508 478 2000
Officers
| Name | Title |
|---|---|
| Dr. Udit Batra Ph.D. | Pres, CEO & Director |
| Mr. Amol Chaubal | Sr. VP & CFO |
| Dr. Belinda Gaye Hyde Ph.D. | Sr. VP & Chief HR Officer |
| Mr. Jonathan M. Pratt | Sr. VP of Waters Division |
| Ms. Jianqing Y. Bennett | Sr. VP of TA Instruments Division |
| Mr. Christos Ross | Sr. VP of Global Operations |
| Caspar Tudor | Manage of Investor Relation |
| Ms. Keeley A. Aleman | Sr. VP, Gen. Counsel & Corp. Sec. |
| Kevin Kempskie | Sr. Director of PR |
| Ms. Kristen Garvey | VP of Corp. Communications |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 27.248 |
|---|---|
| Trailing PE: | 29.5713 |
| Price-to-Book MRQ: | 53.0439 |
| Price-to-Sales TTM: | 6.8962 |
| IPO Date: | 1995-11-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 7800 |